Antimicrobial solutions containing dichlorine monoxide and methods of making and using the same
Methods and products are provided for treating a wound or infection in a mammal or disinfecting a surface with a hypochlorous acid solution that has been activated by a catalyst. Additionally provided is a process for preparing an antimicrobial product that produces an activated hypochlorous acid solution for use as an antimicrobial.
1. An antimicrobial solution, comprising:
a first component comprising an effective amount of a hypochlorous acid solution, wherein the hypochlorous acid solution has a pH of about 4 to about 6, and wherein the hypochlorous acid solution comprises a buffer selected from the group consisting of a phosphate buffer, acetate buffer, citrate buffer, borate buffer, and combinations thereof; and
a second component comprising a catalyst, which catalyzes the conversion of hypochlorous acid into dichlorine monoxide,
wherein, when the first and second components are combined, the combination produces an activated solution comprising a therapeutically effective amount of dichlorine monoxide, and
wherein the activated solution has a pH in a range of from about 4 to about 10.
2. The solution of claim 1 , wherein the hypochlorous acid solution has a pH of from about 5.0 to about 6.0.
3. The solution of claim 1 , wherein the catalyst is selected from the group consisting of a phosphate ion, chloride ion, tertiary amine, sodium hypochlorite, citric acid, and combinations thereof.
4. The solution of claim 1 , wherein the catalyst is triethanolamine.
5. The solution of claim 4 , wherein the triethanolamine is present in a concentration of about 0.3 ppm to about 1.5 ppm.
6. The solution of claim 1 , wherein the activated solution has a pH of from about 5.0 to about 6.0.
7. The solution of claim 1 , wherein the hypochlorous acid solution is contained within a first container, and the catalyst is contained within a second container.
8. A method for treating a wound or infection in a mammal, the method comprising:
adding to a solution comprising an effective amount of hypochlorous acid a catalyst, which catalyzes the conversion of hypochlorous acid into dichlorine monoxide, to produce an activated solution comprising a therapeutically effective amount of dichlorine monoxide; and
administering the activated solution to treat the wound or infection,
wherein the hypochlorous acid solution has a pH of about 4 to about 6,
wherein the activated solution has a pH in a range of from about 4 to about 10, and
wherein the hypochlorous acid solution further comprises a buffer selected from the group consisting of a phosphate buffer, acetate buffer, citrate buffer, borate buffer, and combinations thereof.
9. The method of claim 8 , wherein the hypochlorous acid solution has a pH of from about 5.0 to about 6.0.
10. The method of claim 8 , wherein the catalyst is selected from the group consisting of a phosphate ion, chloride ion, tertiary amine, sodium hypochlorite, citric acid, and combinations thereof.
11. The method of claim 8 , wherein the catalyst is triethanolamine present in a concentration of about 0.3 ppm to about 1.5 ppm.
12. The method of claim 8 , wherein the activated solution has a pH of from about 5.0 to about 6.0.
13. The method of claim 8 , wherein the infection is caused by the bacteria Pseudomonas aeruginosa, Escherichia coli, Enterococcus hirae, Acinetobacter baumannii, Acinetobacter species, Bacteroides fragilis, Enterobacter aerogenes, Enterococcus faecalis , Vancomycin resistant- Enterococcus faecium (VRE, MDR), Haemophilus influenzae, Klebsiella oxytoca, Klebsiella pneumoniae, Micrococcus luteus, Proteus mirabilis, Serratia marcescens, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus saprophyticus, Streptococcus pneumoniae, Streptococcus pyogenes, Salmonella choleraesuis, Shigella dysenteriae or a combination thereof.
14. The method of claim 8 , wherein the wound is an oral ulcer, skin ulcer, burn, peritonitis, periodontal disease, gingival disease or a combination thereof.
15. The method of claim 14 , wherein the skin ulcer is a diabetic foot ulcer.
16. The method of claim 8 , wherein the infection is a pulmonary, ophthalmic, otic, nasal or sinus infection.
17. The method of claim 16 , wherein the pulmonary infection is in a human mammal afflicted with cystic fibrosis.
18. A method for disinfecting a surface, the method comprising:
adding to a solution comprising an effective amount of hypochlorous acid a catalyst, which catalyzes the conversion of hypochlorous acid into dichlorine monoxide, to produce an activated solution comprising a surface-disinfecting effective amount of dichlorine monoxide; and
contacting the surface with the activated solution to disinfect the surface, wherein the hypochlorous acid solution has a pH of about 4 to about 6,
wherein the activated solution has a pH in a range of from about 4 to about 10, and
wherein the hypochlorous acid solution further comprises a buffer selected from the group consisting of a phosphate buffer, acetate buffer, citrate buffer, borate buffer, and combinations thereof.
19. The method of claim 18 , wherein the hypochlorous acid solution has a pH of from about 5.0 to about 6.0.
20. The method of claim 18 , wherein the catalyst is selected from the group consisting of a phosphate ion, chloride ion, tertiary amine, sodium hypochlorite, citric acid, and combinations thereof.
21. The method of claim 18 , wherein the catalyst is triethanolamine in a concentration of about 0.3 ppm to about 1.5 ppm.
22. The method of claim 18 , wherein the surface is a plastic surface, metal surface, glass surface or a combination thereof.
23. The method of claim 18 , wherein the surface is on an artificial heart valve, orthopedic appliance, implantable pacemaker, implantable tube, implantable stent, implantable mesh or a combination thereof.
24. The method of claim 23 , wherein the surface is on a bronchoscope, colonoscope, sigmoidoscope, hysteroscope, laproscope, arthroscope, gastroscope or cystoscope.
25. The solution of claim 1 , wherein the hypochlorous acid solution is prepared by electrolysis.
26. The solution of claim 1 , wherein the hypochlorous acid solution is prepared by dissolving chlorine in a dilute aqueous alkali metal hydroxide solution.
27. The solution of claim 8 , wherein the hypochlorous acid solution is prepared by electrolysis.
28. The solution of claim 8 , wherein the hypochlorous acid solution is prepared by dissolving chlorine in a dilute aqueous alkali metal hydroxide solution.
29. The solution of claim 18 , wherein the hypochlorous acid solution is prepared by electrolysis.
30. The solution of claim 18 , wherein the hypochlorous acid solution is prepared by dissolving chlorine in a dilute aqueous alkali metal hydroxide solution.